bpc-157 vial Reference Material BPC-157 CAPS/VIAL SET - Research

Peptides with a short half-life (like Ipamorelin or CJC-1295 no DAC) require multiple daily injections to maintain stable blood plasma levels

VEGFR2 and angiogenesis pathway: BPC-157 upregulates vascular endothelial growth factor receptor 2 (VEGFR2) expression, stimulating the formation of new capillaries in damaged mucosal tissue

This temperature range slows chemical degradation and bacterial growth

Chemical modification to remove the amyloidogenic motifs

Weaver et al., 2004, 2007

Sikiric, P., Seiwerth, S., Ruman, R., Turkovi, B., Rokotov, D., Bri, L., Sever, M., Klicek, R., Radi, B., Drmic, D., Ili, S., Kolenc, D., Stambolija, V., Zorii, Z., Vri, H., & ebei, B